ARTICLE | Clinical News
GenESA system data
February 22, 1994 8:00 AM UTC
GNSA (San Diego) published abstracts of Phase III studies showing its arbutamine heart stressor is as effective as exercise-induced stress.
Abnormal wall motion in the heart, identified by echochardiography, was detected by the system in 84 percent of 146 patients with confirmed (by angiography) CAD. ...